Koers Tibet Rhodiola Pharmaceutical Holding Co.
Aandelen
600211
CNE000000ZW7
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
37,65 CNY | +2,06% | -1,16% | +0,30% |
Omzet 2024 * | 3,44 mld. 475 mln. 436 mln. | Omzet 2025 * | 4,07 mld. 562 mln. 517 mln. | Marktkapitalisatie | 12,14 mld. 1,67 mld. 1,54 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,02 mld. 141 mln. 130 mln. | Nettowinst (verlies) 2025 * | 1,23 mld. 169 mln. 156 mln. | EV/omzet 2024 * | 3,53 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 2,98 x |
K/w-verhouding 2024 * |
11,9
x | K/w-verhouding 2025 * |
9,89
x | Werknemers | 601 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 37,89% |
1 dag | +2,06% | ||
1 week | -1,16% | ||
Lopende maand | +2,59% | ||
1 maand | +3,37% | ||
3 maanden | +7,60% | ||
6 maanden | -6,24% | ||
Lopend jaar | +0,30% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 54 | - |
Jun Chen
DFI | Director of Finance/CFO | 46 | 01-01-12 |
Yu Cheng Zhou
BRD | Director/Board Member | 42 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Da Bin Chen
CHM | Chairman | 68 | - |
Yu Cheng Zhou
BRD | Director/Board Member | 42 | - |
Yuan Dong Guo
CEO | Chief Executive Officer | 54 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +4,20% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-05-24 | 37,65 | +2,06% | 3 572 270 |
24-05-24 | 36,89 | -0,30% | 2 598 230 |
23-05-24 | 37 | -1,25% | 2 766 865 |
22-05-24 | 37,47 | -0,58% | 2 965 470 |
21-05-24 | 37,69 | -1,05% | 3 255 695 |
slotkoers Shanghai S.E., 27 mei 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,30% | 1,64 mld. | |
+38,51% | 727 mld. | |
+31,74% | 599 mld. | |
-6,23% | 354 mld. | |
+18,78% | 328 mld. | |
+1,35% | 277 mld. | |
+16,00% | 243 mld. | |
+8,44% | 205 mld. | |
-5,97% | 203 mld. | |
+6,19% | 164 mld. |